Workflow
*ST长药: 关于收到股东临时提案的公告

Group 1 - The core point of the announcement is that Changjiang Pharmaceutical Holdings Co., Ltd. is adding a temporary proposal to its upcoming third extraordinary general meeting of shareholders, which includes the nomination of a new independent director candidate [1] - The controlling shareholder, Shengshi Fenghua Business Co., Ltd., has nominated Mr. Wei Jian as the independent director candidate due to Mr. Yang Changsheng's withdrawal from the nomination [1] - Shengshi Fenghua holds 35,423,600 shares, representing 10.11% of the total share capital of the company, and is eligible to submit the temporary proposal [1][2] Group 2 - The board of directors confirms that the temporary proposal complies with relevant laws, regulations, and the company's articles of association [1] - The temporary proposal will be submitted as the 2.03 proposal for the extraordinary general meeting of shareholders [1]